Skip to main content
Erschienen in: European Journal of Pediatrics 8/2009

01.08.2009 | Short Report

Sulphasalazine treatment in protracted familial Mediterranean fever arthritis

verfasst von: Sevcan A. Bakkaloglu, Tekin Aksu, Berna Goker, Aysel Unlusoy, Harun Peru, Kibriya Fidan, Oguz Soylemezoglu, Enver Hasanoglu, Necla Buyan

Erschienen in: European Journal of Pediatrics | Ausgabe 8/2009

Einloggen, um Zugang zu erhalten

Abstract

Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by self-limited attacks of fever and polyserositis. Articular involvement in early-onset FMF is a common finding characterized by non-erosive, generally asymmetric monoarthritis in large joints. Protracted FMF arthritis was reported in 2.6% of Turkish patients. An 8-year-old female who has a history of FMF for 5 years applied to our hospital with complaints of persistent swelling and pain of her left knee for 8 months. The patient had been tried to be managed with non-steroidal anti-inflammatory drugs as well as intra-articulary steroids and colchicine. However, arthritis and acute phase response persisted. With sulphasalazine, complete recovery was achieved. It is our belief that sulphasalazine can be a choice of medical treatment in protracted FMF arthritis.
Literatur
1.
Zurück zum Zitat Bodur H, Ucan H, Seckin S et al (1999) Protracted familial Mediterranean fever arthritis. Rheumatol Int 19:71–73PubMedCrossRef Bodur H, Ucan H, Seckin S et al (1999) Protracted familial Mediterranean fever arthritis. Rheumatol Int 19:71–73PubMedCrossRef
2.
Zurück zum Zitat Calguneri M, Apras S, Ozbalkan Z et al (2004) The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol 22(4 Suppl 34):S41–S44PubMed Calguneri M, Apras S, Ozbalkan Z et al (2004) The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients. Clin Exp Rheumatol 22(4 Suppl 34):S41–S44PubMed
3.
Zurück zum Zitat Garcia Gonzalez A, Weisman MH (1992) The arthritis of familial Mediterranean fever. Semin Arthritis Rheum. 22:139–150PubMedCrossRef Garcia Gonzalez A, Weisman MH (1992) The arthritis of familial Mediterranean fever. Semin Arthritis Rheum. 22:139–150PubMedCrossRef
4.
Zurück zum Zitat Lidar M, Kedem R, Mor A et al (2005) Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 32(5):859–862PubMed Lidar M, Kedem R, Mor A et al (2005) Arthritis as the sole episodic manifestation of familial Mediterranean fever. J Rheumatol 32(5):859–862PubMed
5.
Zurück zum Zitat Majeed HA, Rawashdeh M (1997) The clinical patterns of arthritis in children with familial Mediterranean fever. Q J Med 90:37–43 Majeed HA, Rawashdeh M (1997) The clinical patterns of arthritis in children with familial Mediterranean fever. Q J Med 90:37–43
6.
Zurück zum Zitat Mor A, Pillinger MH, Kishimoto M et al (2007) Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13(1):38–40PubMedCrossRef Mor A, Pillinger MH, Kishimoto M et al (2007) Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13(1):38–40PubMedCrossRef
7.
Zurück zum Zitat Sakallioglu O, Duzova A, Ozen S (2006) Etanercept in the treatment of arthritis in a patient with FMF. Clin Exp Rheumatol 24(4):435–437PubMed Sakallioglu O, Duzova A, Ozen S (2006) Etanercept in the treatment of arthritis in a patient with FMF. Clin Exp Rheumatol 24(4):435–437PubMed
8.
Zurück zum Zitat Salai M, Zemmer D, Segal E et al (1997) Chronic massive knee effusion in familial Mediterranean fever. Semin Arthritis Rheum 27(3):169–172PubMedCrossRef Salai M, Zemmer D, Segal E et al (1997) Chronic massive knee effusion in familial Mediterranean fever. Semin Arthritis Rheum 27(3):169–172PubMedCrossRef
9.
Zurück zum Zitat Seyahi E, Ozdogan H, Masatlioglu S, Yazici H (2002) Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. Clin Exp Rheumatol 20(Suppl.26):S43–S44PubMed Seyahi E, Ozdogan H, Masatlioglu S, Yazici H (2002) Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient. Clin Exp Rheumatol 20(Suppl.26):S43–S44PubMed
10.
Zurück zum Zitat Turkish FMF study group (2005) Familial Mediterranean fever in Turkey: results of a nationwide multicenter study. Medicine 84:1–11CrossRef Turkish FMF study group (2005) Familial Mediterranean fever in Turkey: results of a nationwide multicenter study. Medicine 84:1–11CrossRef
11.
Zurück zum Zitat Ureten K, Calguneri M, Onat AM et al (2004) Interferon alpha in protracted arthritis of familial Mediterranean fever: a robust alternative for synovectomy. Ann Rheum Dis 63(11):1527PubMedCrossRef Ureten K, Calguneri M, Onat AM et al (2004) Interferon alpha in protracted arthritis of familial Mediterranean fever: a robust alternative for synovectomy. Ann Rheum Dis 63(11):1527PubMedCrossRef
12.
Zurück zum Zitat Yalcınkaya F, Tekin M, Tumer N, Ozkaya N (1997) Protracted arthritis of familial Mediterranean fever (an unusual complication). Br J Rheumatol 36:1228–1230PubMedCrossRef Yalcınkaya F, Tekin M, Tumer N, Ozkaya N (1997) Protracted arthritis of familial Mediterranean fever (an unusual complication). Br J Rheumatol 36:1228–1230PubMedCrossRef
Metadaten
Titel
Sulphasalazine treatment in protracted familial Mediterranean fever arthritis
verfasst von
Sevcan A. Bakkaloglu
Tekin Aksu
Berna Goker
Aysel Unlusoy
Harun Peru
Kibriya Fidan
Oguz Soylemezoglu
Enver Hasanoglu
Necla Buyan
Publikationsdatum
01.08.2009
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 8/2009
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-008-0875-y

Weitere Artikel der Ausgabe 8/2009

European Journal of Pediatrics 8/2009 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.